Correspondence on "Maternal carrier screening with single-gene NIPS provides accurate fetal risk assessments for recessive conditions" by Hoskovec et al.

[1]  G. Heiman,et al.  Rate of manifesting carriers and other unexpected findings on carrier screening , 2022, Prenatal diagnosis.

[2]  J. Wynn,et al.  Maternal carrier screening with single-gene NIPS provides accurate fetal risk assessments for recessive conditions. , 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

[3]  Lisa Campo-Engelstein,et al.  An Ethical Argument for Health Insurance Coverage of Paternal Prenatal Genetic Testing. , 2022, Obstetrics and gynecology.

[4]  I. Vogel,et al.  Noninvasive prenatal screening for cystic fibrosis using circulating trophoblasts: Detection of the 50 most common disease‐causing variants , 2022, Prenatal diagnosis.

[5]  P. Ricciardi-Castagnoli,et al.  Isolation of single circulating trophoblasts from maternal circulation for noninvasive fetal copy number variant profiling , 2022, Prenatal diagnosis.

[6]  M. Gelb,et al.  In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe's Disease. , 2022, The New England journal of medicine.

[7]  N. Leach,et al.  Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG) , 2021, Genetics in Medicine.

[8]  C. Eng,et al.  Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach , 2020, Genetics in Medicine.

[9]  Balaji S. Srinivasan,et al.  An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals , 2012, Genetics in Medicine.

[10]  H B Newcombe,et al.  Genetic disorders in children and young adults: a population study. , 1988, American journal of human genetics.